[144] Planet Labs PBC SEC Filing

Rhea-AI Filing Summary

Planet Labs PBC (PL) has filed a Form 144 indicating an intended sale of insider shares. The notice covers up to 3,011,400 common shares to be sold through Morgan Stanley Smith Barney beginning on or about 11 July 2025. At the filing date, the shares carry an aggregate market value of $19.88 million and represent roughly 1.1 % of the company’s 282,273,344 shares outstanding.

The shares were originally acquired as Founder Shares on 5 March 2021. Recent Form 144 disclosure shows that the same account, Isalea Investments LP, has already sold 12,400 shares in two small transactions on 12 and 13 June 2025, generating gross proceeds of $8,293.12.

While insider dispositions can signal reduced confidence, the percentage of shares involved is modest and the filing complies with Rule 144’s disclosure requirements, allowing investors to monitor potential selling pressure without implying immediate dilution to existing shareholders.

Positive

• Sale represents only ~1.1 % of total shares outstanding, limiting dilution and market supply impact.
• Full Rule 144 disclosure with broker, dates and share counts demonstrates transparent compliance and lowers governance risk.

Negative

• Insider intends to sell $19.9 M worth of shares, which may signal reduced confidence and create near-term selling pressure.

Insights

Equity Research Analyst

TL;DR – Insider plans to sell 3 M shares (~1 %) worth $19.9 M; limited but watch for sentiment impact.

Form 144s flag prospective insider sales. The proposed 3,011,400-share sale equals only 1.1 % of outstanding stock, so dilution is immaterial. Still, insider selling totaling nearly $20 M may weigh on near-term sentiment, especially after small June sales already executed. No valuation or operational data are included, so this filing is purely about potential secondary supply rather than fundamental change. I view the disclosure as neutral unless follow-on sales accelerate.

Corporate Governance Specialist

TL;DR – Filing shows compliance with Rule 144; transaction size modest; governance risk low.

The filer followed Rule 144’s advance-notice protocol, disclosing broker, share count and acquisition history. The 10b5-1 attestation mitigates concerns of trading on non-public information. Because the stake is small relative to total float and shares are founder-held, no control shift occurs. From a governance perspective, this is a routine, transparent insider sale, carrying neutral impact for shareholders.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3011400	19875240.00	282273344	07/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/05/2021	Founders Shares	Issuer			3011400	03/05/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ISALEA INVESTMENTS LP 645 Harrison Street Floor 4 San Francisco CA 94107	Common	06/13/2025	3800	2443.40
ISALEA INVESTMENTS LP 645 Harrison Street Floor 4 San Francisco CA 94107	Common	06/12/2025	8600	5849.72

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Planet Labs (PL) shares are being registered for sale in this Form 144?

Up to 3,011,400 common shares are covered by the notice.

What percentage of Planet Labs’ outstanding shares does the planned sale represent?

Approximately 1.1 % of the 282,273,344 shares outstanding.

Who is the selling account listed in the filing?

The address information points to Isalea Investments LP as the selling entity.

When is the earliest anticipated sale date for the shares?

The filing lists an approximate sale date of 11 July 2025.

Which broker will handle the transaction?

Sales are to be executed through Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.